A new report titled “ Molecular Imaging Device Market – Forecast to 2032” by Eternal Market, the global molecular imaging device industry is projected to grow at a compound annual growth rate (CAGR) of 10.8% from 2023 to 2032, reaching a value of USD 14,245.6 million by the end of the forecast period.
Global molecular imaging device industry outlook
Molecular imaging devices represent advanced medical imaging systems designed for the visualization and analysis of molecular and cellular processes occurring within living organisms. These cutting-edge devices leverage various imaging modalities, including positron emission tomography (PET), single-photon emission computed tomography (SPECT), magnetic resonance imaging (MRI), and computed tomography (CT), to produce high-resolution images that unveil intricate biological processes at the molecular and cellular scale.
These molecular imaging devices play a pivotal role in the diagnosis and treatment of a diverse spectrum of diseases encompassing cancer, cardiovascular disorders, neurological ailments, and metabolic conditions. Moreover, they are instrumental in drug development and research endeavors, enabling non-invasive monitoring of drug distribution and pharmacokinetics within living organisms. These devices employ specialized imaging agents, such as contrast agents and radiopharmaceuticals, tailored to target specific molecules and cells within the body.
Key Visions
- Estimated CAGR of around 10.8% over the forecast period (2023-2032).
- Global molecular imaging devices Industry size is projected to reach USD 14,245.6 million by 2032 from USD 4,978.4 million in 2022.
- Rising investment in research and development is the key market driver.
- By technology, in 2023, Positron Emission Tomography (PET) segment is estimated to hold largest market share.
- By type of imaging agents, radiopharmaceuticals segment likely to be the largest revenue contributor in 2023.
- North America to lead the market in 2023.
Global molecular imaging device industry forces
Growing prevalence of chronic diseases.
Chronic diseases, such as cancer, cardiovascular diseases, and neurological disorders, are a major burden on healthcare systems worldwide. Molecular imaging devices play a crucial role in the diagnosis and monitoring of these diseases. As the incidence and prevalence of chronic diseases continue to rise globally, the demand for molecular imaging devices is expected to increase.
Advancements in imaging technology.
Molecular imaging technology has undergone significant advancements in recent years. Hybrid imaging devices, which combine different imaging modalities such as positron emission tomography (PET) and computed tomography (CT), have improved the accuracy and sensitivity of diagnosis. This has led to increased adoption of molecular imaging devices in both clinical and research settings. Other technological advancements, such as the development of high-resolution imaging techniques, have also contributed to the growth of the market.
Rising investment in research and development.
Governments, academic institutions, and private companies are investing heavily in research and development of new molecular imaging devices and technologies. This is driving the development of more advanced and sophisticated molecular imaging devices, which are better equipped to diagnose and monitor diseases at an early stage. In addition, the development of new imaging agents, such as contrast agents and radiopharmaceuticals, is also contributing to the growth of the market.
Growing demand for non-invasive diagnosis.
Non-invasive diagnostic procedures are becoming increasingly popular among patients as they are less painful and pose a lower risk of infection. Molecular imaging devices allow for non-invasive diagnosis of diseases, which is a major advantage over traditional diagnostic procedures that require invasive procedures. As patients increasingly demand non-invasive diagnostic procedures, the demand for molecular imaging devices is expected to rise.
Increasing geriatric population.
The increasing geriatric population is a driver for the growth of the molecular imaging device market because the elderly population is more susceptible to chronic diseases such as cancer, cardiovascular diseases, and neurological disorders. As people age, the risk of developing chronic diseases increases, leading to a higher demand for diagnostic tools such as molecular imaging devices. Moreover, the geriatric population requires more frequent and specialized medical care, which drives the demand for advanced diagnostic tools. Molecular imaging devices offer several benefits over traditional diagnostic tools, such as the ability to provide more precise and detailed information about the molecular and cellular processes involved in disease development, progression, and treatment. This is particularly important in the case of geriatric patients, who often have complex medical conditions and require personalized treatment plans. In addition, the aging population represents a significant market opportunity for molecular imaging device manufacturers. As the population ages, the demand for diagnostic tools is expected to increase, leading to higher sales and revenue for manufacturers.
Global molecular imaging device industry segments
The global molecular imaging device market is segmented based on Technology (Positron Emission Tomography (PET), Single-Photon Emission Computed Tomography (SPECT), Magnetic Resonance Imaging (MRI), Computed Tomography (CT)), Application (Oncology, Cardiology, Neurology, Others), End-user (Hospitals, Diagnostic Imaging Centers, Research Institutes), Type of Imaging Agents (Radiopharmaceuticals, Contrast Agents, Optical)
Based on Technology, PET technology has been growing at a relatively faster rate compared to other technologies. This is due to its ability to provide high-resolution images and its wide range of applications in oncology, neurology, and cardiology. PET technology is also expected to grow due to advancements in radiopharmaceuticals and molecular imaging agents, which enhance the sensitivity and specificity of PET imaging. On the other hand, SPECT technology is also expected to grow due to its lower cost compared to PET technology and its ability to provide functional information about organs and tissues.
Based on Application, the oncology application is expected to grow at the highest rate in the molecular imaging device market. This is due to the increasing incidence of cancer globally and the need for early and accurate diagnosis of cancer. Molecular imaging devices, particularly PET and SPECT, play a vital role in oncology by detecting early-stage cancer and monitoring cancer progression and treatment response. The use of molecular imaging in oncology also enables physicians to personalize treatment plans for cancer patients based on their individual needs. Apart from oncology, the neurology application is also expected to grow at a high rate due to the increasing prevalence of neurological disorders such as Alzheimer’s and Parkinson’s disease. Molecular imaging devices, particularly PET, are used to study the biological mechanisms of these disorders and develop new treatments. The use of molecular imaging in neurology also enables physicians to monitor disease progression and assess the effectiveness of treatment.
Based on End-user, the hospitals segment is expected to grow at the highest rate in the molecular imaging device market. This is due to the increasing demand for advanced diagnostic technologies in hospitals for the diagnosis and treatment of various diseases. Hospitals are the primary healthcare providers for patients and have the highest patient footfall, leading to a high demand for molecular imaging devices.
Based on type of imaging agents, the radiopharmaceuticals segment is expected to grow at the highest rate in the molecular imaging device market. This is due to the increasing use of radiopharmaceuticals in molecular imaging procedures and the development of new radiopharmaceuticals for various applications. Radiopharmaceuticals are substances that contain a radioactive element and are used to diagnose and treat various diseases, particularly cancer and neurological disorders.
Global molecular imaging device industry players
Key players operating in the global Molecular Imaging Device market include Siemens Healthineers AG, General Electric Company, Philips Healthcare, Canon Medical Systems Corporation, Bruker Corporation, PerkinElmer Inc., FUJIFILM Holdings Corporation, Toshiba Corporation, Mediso Ltd., MILabs B.V., MR Solutions Ltd., Aspect Imaging Ltd., Agfa-Gevaert N.V., Cubresa Inc., Naviscan Inc., among others.
Industry Developments:
In 2021, Siemens Healthineers acquired Varian Medical Systems, a leading provider of cancer care solutions, to expand its oncology portfolio.
In 2021, GE Healthcare launched the Discovery MI Gen 2, a PET/CT scanner that offers high-resolution imaging and improved diagnostic accuracy.
In 2021, Philips Healthcare launched the Vereos PET/CT, a high-resolution PET/CT system that offers improved image quality and reduced radiation exposure.
In 2021, Canon Medical Systems launched the Vantage Orian 1.5T, an MRI system that offers advanced imaging capabilities and improved patient comfort.
In 2021, Bruker Corporation launched the SiTe™ silicon drift detector for energy-dispersive X-ray spectroscopy, which offers improved sensitivity and resolution for elemental analysis.
Major Strategies adopted by key market players
- Agreements, Collaborations, and Partnerships: 33%
- Acquisitions: _%
- New Product Launch: 15%
- Other Developments: _%
Scope of the Report:
Global Molecular Imaging Device Market, by Technology
- Positron Emission Tomography (PET)
- Single-Photon Emission Computed Tomography (SPECT)
- Magnetic Resonance Imaging (MRI)
- Computed Tomography (CT)
Global Molecular Imaging Device Market, by Application
- Oncology
- Cardiology
- Neurology
- Other Applications
Global Molecular Imaging Device Market, by End-user
- Hospitals
- Diagnostic Imaging Centers
- Research Institutes
Global Molecular Imaging Device Market, by Type of Imaging Agents
- Radiopharmaceuticals
- Contrast Agents
- Optical
Global Molecular Imaging Device Market, by Geography
- North America
- Europe
- Germany
- U.K.
- France
- Italy
- Spain
- Rest of Europe (RoE)
- Asia-Pacific (APAC)
- China
- Japan
- India
- Rest of APAC (RoAPAC)
-
- Brazil
- Argentina
- Rest of South America
Companies Profiled
- Siemens Healthineers AG
- General Electric Company
- Philips Healthcare
- Canon Medical Systems Corporation
- Bruker Corporation
- PerkinElmer Inc.
- FUJIFILM Holdings Corporation
- Toshiba Corporation
- Mediso Ltd.
- MILabs B.V.
- MR Solutions Ltd.
- Aspect Imaging Ltd.
- Agfa-Gevaert N.V.
- Cubresa Inc.
- Naviscan Inc.
- Other Companies
*The report scope shall be customized as per the requirements
Chapter 1 Global Molecular Imaging Device Market Overview
1.1 Introduction
1.2 Drivers for Molecular Imaging Device Market
1.3 Restraints for Molecular Imaging Device Market
1.4 Opportunities for Molecular Imaging Device Market
1.5 Trends for Molecular Imaging Device Market
1.6 Macro-economic Factors
1.7 Regulatory Framework
1.8 Opportunity Map Analysis
1.9 Opportunity Orbits
1.10 Market Investment Feasibility Index
1.11 PEST Analysis
1.12 PORTER’S Five Force Analysis
1.13 Go to Market Strategy
1.14 Marketing Strategy
1.15 Technology Roadmap
1.16 Advances in product/services adoption worldwide
1.17 Regional Market Share and BPS Analysis
Chapter 2 Global Molecular Imaging Device Market Competitive Analysis
2.1 Market Competition Scenario Analysis, By Company
2.2 Competitor Landscape
2.3 Major Strategies adopted by key market players (2020-2022)
2.4 Recent Developments/Investments/Announcements
2.5 Company Profiles
2.5.1 Siemens Healthineers AG
2.5.1.1 Company Overview
2.5.1.2 Business Description
2.5.1.3 Product Portfolio
2.5.1.4 Key Financials
2.5.1.5 Company Presence & Business Segment Analysis – 2022
2.5.1.6 Key Developments
2.5.1.7 SWOT Analysis
2.5.2 General Electric Company
2.5.2.1 Company Overview
2.5.2.2 Business Description
2.5.2.3 Product Portfolio
2.5.2.4 Key Financials
2.5.2.5 Company Presence & Business Segment Analysis – 2022
2.5.2.6 Key Developments
2.5.2.7 SWOT Analysis
2.5.3 Philips Healthcare
2.5.3.1 Company Overview
2.5.3.2 Business Description
2.5.3.3 Product Portfolio
2.5.3.4 Key Financials
2.5.3.5 Company Presence & Business Segment Analysis – 2022
2.5.3.6 Key Developments
2.5.3.7 SWOT Analysis
2.5.4 Canon Medical Systems Corporation
2.5.4.1 Company Overview
2.5.4.2 Business Description
2.5.4.3 Product Portfolio
2.5.4.4 Key Financials
2.5.4.5 Company Presence & Business Segment Analysis – 2022
2.5.4.6 Key Developments
2.5.4.7 SWOT Analysis
2.5.5 Bruker Corporation
2.5.5.1 Company Overview
2.5.5.2 Business Description
2.5.5.3 Product Portfolio
2.5.5.4 Key Financials
2.5.5.5 Company Presence & Business Segment Analysis – 2022
2.5.5.6 Key Developments
2.5.5.7 SWOT Analysis
2.5.6 PerkinElmer Inc.
2.5.6.1 Company Overview
2.5.6.2 Business Description
2.5.6.3 Product Portfolio
2.5.6.4 Key Financials
2.5.6.5 Company Presence & Business Segment Analysis – 2022
2.5.6.6 Key Developments
2.5.6.7 SWOT Analysis
2.5.7 FUJIFILM Holdings Corporation
2.5.7.1 Company Overview
2.5.7.2 Business Description
2.5.7.3 Product Portfolio
2.5.7.4 Key Financials
2.5.7.5 Company Presence & Business Segment Analysis – 2022
2.5.7.6 Key Developments
2.5.7.7 SWOT Analysis
2.5.8 Toshiba Corporation
2.5.8.1 Company Overview
2.5.8.2 Business Description
2.5.8.3 Product Portfolio
2.5.8.4 Key Financials
2.5.8.5 Company Presence & Business Segment Analysis – 2022
2.5.8.6 Key Developments
2.5.8.7 SWOT Analysis
2.5.9 Mediso Ltd.
2.5.9.1 Company Overview
2.5.9.2 Business Description
2.5.9.3 Product Portfolio
2.5.9.4 Key Financials
2.5.9.5 Company Presence & Business Segment Analysis – 2022
2.5.9.6 Key Developments
2.5.9.7 SWOT Analysis
2.5.10 MILabs B.V.
2.5.10.1 Company Overview
2.5.10.2 Business Description
2.5.10.3 Product Portfolio
2.5.10.4 Key Financials
2.5.10.5 Company Presence & Business Segment Analysis – 2022
2.5.10.6 Key Developments
2.5.10.7 SWOT Analysis
Chapter 3 Global Molecular Imaging Device Market Overview
3.1 Global Molecular Imaging Device Market Outlook (2017-2032)
3.1.1 Global Molecular Imaging Device Market Value (US$ Mn) and Volume (Units) (2017-2023)
3.1.2 Global Molecular Imaging Device Market Value (US$ Mn) and Volume (Units) (2024-2032)
3.2 Global Molecular Imaging Device Market by Region
3.2.1 Global Molecular Imaging Device Market Value (US$ Mn) and Volume (Units) Comparison by Region (2017-2032)
3.2.2 Global Molecular Imaging Device Market Attractiveness Analysis by Region, 2023–2032
3.3 Global Molecular Imaging Device Market by Technology
3.3.1 Global Molecular Imaging Device Market Value (US$ Mn) and Volume (Units) Comparison by Technology (2017-2032)
3.3.2 Global Molecular Imaging Device Market Attractiveness Analysis by Technology, 2023–2032
3.3.3 Global Molecular Imaging Device Market Attractiveness Analysis by Region, 2023–2032
3.4 Global Molecular Imaging Device Market by Type of Imaging Agents
3.4.1 Global Molecular Imaging Device Market Value (US$ Mn) and Volume (Units) Comparison by Type of Imaging Agents (2017-2032)
3.4.2 Global Molecular Imaging Device Market Attractiveness Analysis by Type of Imaging Agents, 2023–2032
3.5 Global Molecular Imaging Device Market Value (US$ Mn) and Volume (Units) by Region
3.5.1 Global Molecular Imaging Device Market Value (US$ Mn) and Volume (Units) Comparison by Region (2017-2023)
3.5.2 Global Molecular Imaging Device Market Value (US$ Mn) and Volume (Units) Comparison by Region (2024-2032)
3.6 Global Molecular Imaging Device Market Value (US$ Mn) and Volume (Units) by Technology
3.6.1 Global Molecular Imaging Device Market Value (US$ Mn) and Volume (Units) Comparison by Technology (2017-2023)
3.6.2 Global Molecular Imaging Device Market Value (US$ Mn) and Volume (Units) Comparison by Technology (2024-2032)
3.7 Global Molecular Imaging Device Market Value (US$ Mn) and Volume (Units) by Type of Imaging Agents
3.7.1 Global Molecular Imaging Device Market Value (US$ Mn) and Volume (Units) Comparison by Type of Imaging Agents (2017-2023)
3.7.2 Global Molecular Imaging Device Market Value (US$ Mn) and Volume (Units) Comparison by Type of Imaging Agents (2024-2032)
3.8 Global Molecular Imaging Device Market Y-o-Y Growth Rate Comparison 2018–2032
3.8.1 Global Molecular Imaging Device Market Y-o-Y Growth Rate by Region
3.8.2 Global Molecular Imaging Device Market Y-o-Y Growth Rate by Technology
3.8.3 Global Molecular Imaging Device Market Y-o-Y Growth Rate by Type of Imaging Agents
3.9 Global Molecular Imaging Device Market Share Comparison 2017–2032
3.9.1 Global Molecular Imaging Device Market Share by Region
3.9.2 Global Molecular Imaging Device Market Share by Technology
3.9.3 Global Molecular Imaging Device Market Share by Type of Imaging Agents
Chapter 4 North America Molecular Imaging Device Market Overview
4.1 North America Market Snapshot
4.1.1 Regional Overview
4.1.1.1 US
4.1.1.2 Canada
4.1.1.3 Mexico
4.2 North America Molecular Imaging Device Market Outlook (2017-2032)
4.2.1 North America Molecular Imaging Device Market Value (US$ Mn) and Volume (Units) (2017-2023)
4.2.2 North America Molecular Imaging Device Market Value (US$ Mn) and Volume (Units) (2024-2032)
4.3 North America Molecular Imaging Device Market by Region
4.3.1 North America Molecular Imaging Device Market Value (US$ Mn) and Volume (Units) Comparison by Region (2017-2032)
4.3.2 North America Molecular Imaging Device Market Attractiveness Analysis by Region, 2023–2032
4.4 North America Molecular Imaging Device Market by Technology
4.4.1 North America Molecular Imaging Device Market Value (US$ Mn) and Volume (Units) Comparison by Technology (2017-2032)
4.4.2 North America Molecular Imaging Device Market Attractiveness Analysis by Technology, 2023–2032
4.4.3 North America Molecular Imaging Device Market Attractiveness Analysis by Region, 2023–2032
4.5 North America Molecular Imaging Device Market by Type of Imaging Agents
4.5.1 North America Molecular Imaging Device Market Value (US$ Mn) and Volume (Units) Comparison by Type of Imaging Agents (2017-2032)
4.5.2 North America Molecular Imaging Device Market Attractiveness Analysis by Type of Imaging Agents, 2023–2032
4.6 North America Molecular Imaging Device Market Value (US$ Mn) and Volume (Units) by Region
4.6.1 North America Molecular Imaging Device Market Value (US$ Mn) and Volume (Units) Comparison by Region (2017-2023)
4.6.2 North America Molecular Imaging Device Market Value (US$ Mn) and Volume (Units) Comparison by Region (2024-2032)
4.7 North America Molecular Imaging Device Market Value (US$ Mn) and Volume (Units) by Technology
4.7.1 North America Molecular Imaging Device Market Value (US$ Mn) and Volume (Units) Comparison by Technology (2017-2023)
4.7.2 North America Molecular Imaging Device Market Value (US$ Mn) and Volume (Units) Comparison by Technology (2024-2032)
4.8 North America Molecular Imaging Device Market Value (US$ Mn) and Volume (Units) by Type of Imaging Agents
4.8.1 North America Molecular Imaging Device Market Value (US$ Mn) and Volume (Units) Comparison by Type of Imaging Agents (2017-2023)
4.8.2 North America Molecular Imaging Device Market Value (US$ Mn) and Volume (Units) Comparison by Type of Imaging Agents (2024-2032)
4.9 North America Molecular Imaging Device Market Y-o-Y Growth Rate Comparison 2018–2032
4.9.1 North America Molecular Imaging Device Market Y-o-Y Growth Rate by Region
4.9.2 North America Molecular Imaging Device Market Y-o-Y Growth Rate by Technology
4.9.3 North America Molecular Imaging Device Market Y-o-Y Growth Rate by Type of Imaging Agents
4.1 North America Molecular Imaging Device Market Share Comparison 2017–2032
4.10.1 North America Molecular Imaging Device Market Share by Region
4.10.2 North America Molecular Imaging Device Market Share by Technology
4.10.3 North America Molecular Imaging Device Market Share by Type of Imaging Agents
Chapter 5 Europe Molecular Imaging Device Market Overview
5.1 Europe Market Snapshot
5.1.1 Regional Overview
5.1.1.1 Germany
5.1.1.2 United Kingdom
5.1.1.3 France
5.1.1.4 Italy
5.1.1.5 Spain
5.1.1.6 Russia
5.1.1.7 Rest of Europe
5.2 Europe Molecular Imaging Device Market Outlook (2017-2032)
5.2.1 Europe Molecular Imaging Device Market Value (US$ Mn) and Volume (Units) (2017-2023)
5.2.2 Europe Molecular Imaging Device Market Value (US$ Mn) and Volume (Units) (2024-2032)
5.3 Europe Molecular Imaging Device Market by Region
5.3.1 Europe Molecular Imaging Device Market Value (US$ Mn) and Volume (Units) Comparison by Region (2017-2032)
5.3.2 Europe Molecular Imaging Device Market Attractiveness Analysis by Region, 2023–2032
5.4 Europe Molecular Imaging Device Market by Technology
5.4.1 Europe Molecular Imaging Device Market Value (US$ Mn) and Volume (Units) Comparison by Technology (2017-2032)
5.4.2 Europe Molecular Imaging Device Market Attractiveness Analysis by Technology, 2023–2032
5.4.3 Europe Molecular Imaging Device Market Attractiveness Analysis by Region, 2023–2032
5.5 Europe Molecular Imaging Device Market by Type of Imaging Agents
5.5.1 Europe Molecular Imaging Device Market Value (US$ Mn) and Volume (Units) Comparison by Type of Imaging Agents (2017-2032)
5.5.2 Europe Molecular Imaging Device Market Attractiveness Analysis by Type of Imaging Agents, 2023–2032
5.6 Europe Molecular Imaging Device Market Value (US$ Mn) and Volume (Units) by Region
5.6.1 Europe Molecular Imaging Device Market Value (US$ Mn) and Volume (Units) Comparison by Region (2017-2023)
5.6.2 Europe Molecular Imaging Device Market Value (US$ Mn) and Volume (Units) Comparison by Region (2024-2032)
5.7 Europe Molecular Imaging Device Market Value (US$ Mn) and Volume (Units) by Technology
5.7.1 Europe Molecular Imaging Device Market Value (US$ Mn) and Volume (Units) Comparison by Technology (2017-2023)
5.7.2 Europe Molecular Imaging Device Market Value (US$ Mn) and Volume (Units) Comparison by Technology (2024-2032)
5.8 Europe Molecular Imaging Device Market Value (US$ Mn) and Volume (Units) by Type of Imaging Agents
5.8.1 Europe Molecular Imaging Device Market Value (US$ Mn) and Volume (Units) Comparison by Type of Imaging Agents (2017-2023)
5.8.2 Europe Molecular Imaging Device Market Value (US$ Mn) and Volume (Units) Comparison by Type of Imaging Agents (2024-2032)
5.9 Europe Molecular Imaging Device Market Y-o-Y Growth Rate Comparison 2018–2032
5.9.1 Europe Molecular Imaging Device Market Y-o-Y Growth Rate by Region
5.9.2 Europe Molecular Imaging Device Market Y-o-Y Growth Rate by Technology
5.9.3 Europe Molecular Imaging Device Market Y-o-Y Growth Rate by Type of Imaging Agents
5.1 Europe Molecular Imaging Device Market Share Comparison 2017–2032
5.10.1 Europe Molecular Imaging Device Market Share by Region
5.10.2 Europe Molecular Imaging Device Market Share by Technology
5.10.3 Europe Molecular Imaging Device Market Share by Type of Imaging Agents
Chapter 6 Asia Pacific Molecular Imaging Device Market Overview
6.1 Asia Pacific Market Snapshot
6.1.1 Regional Overview
6.1.1.1 China
6.1.1.2 India
6.1.1.3 Japan
6.1.1.4 Australia
6.1.1.5 Rest of Asia Pacific
6.2 Asia Pacific Molecular Imaging Device Market Outlook (2017-2032)
6.2.1 Asia Pacific Molecular Imaging Device Market Value (US$ Mn) and Volume (Units) (2017-2023)
6.2.2 Asia Pacific Molecular Imaging Device Market Value (US$ Mn) and Volume (Units) (2024-2032)
6.3 Asia Pacific Molecular Imaging Device Market by Region
6.3.1 Asia Pacific Molecular Imaging Device Market Value (US$ Mn) and Volume (Units) Comparison by Region (2017-2032)
6.3.2 Asia Pacific Molecular Imaging Device Market Attractiveness Analysis by Region, 2023–2032
6.4 Asia Pacific Molecular Imaging Device Market by Technology
6.4.1 Asia Pacific Molecular Imaging Device Market Value (US$ Mn) and Volume (Units) Comparison by Technology (2017-2032)
6.4.2 Asia Pacific Molecular Imaging Device Market Attractiveness Analysis by Technology, 2023–2032
6.4.3 Asia Pacific Molecular Imaging Device Market Attractiveness Analysis by Region, 2023–2032
6.5 Asia Pacific Molecular Imaging Device Market by Type of Imaging Agents
6.5.1 Asia Pacific Molecular Imaging Device Market Value (US$ Mn) and Volume (Units) Comparison by Type of Imaging Agents (2017-2032)
6.5.2 Asia Pacific Molecular Imaging Device Market Attractiveness Analysis by Type of Imaging Agents, 2023–2032
6.6 Asia Pacific Molecular Imaging Device Market Value (US$ Mn) and Volume (Units) by Region
6.6.1 Asia Pacific Molecular Imaging Device Market Value (US$ Mn) and Volume (Units) Comparison by Region (2017-2023)
6.6.2 Asia Pacific Molecular Imaging Device Market Value (US$ Mn) and Volume (Units) Comparison by Region (2024-2032)
6.7 Asia Pacific Molecular Imaging Device Market Value (US$ Mn) and Volume (Units) by Technology
6.7.1 Asia Pacific Molecular Imaging Device Market Value (US$ Mn) and Volume (Units) Comparison by Technology (2017-2023)
6.7.2 Asia Pacific Molecular Imaging Device Market Value (US$ Mn) and Volume (Units) Comparison by Technology (2024-2032)
6.8 Asia Pacific Molecular Imaging Device Market Value (US$ Mn) and Volume (Units) by Type of Imaging Agents
6.8.1 Asia Pacific Molecular Imaging Device Market Value (US$ Mn) and Volume (Units) Comparison by Type of Imaging Agents (2017-2023)
6.8.2 Asia Pacific Molecular Imaging Device Market Value (US$ Mn) and Volume (Units) Comparison by Type of Imaging Agents (2024-2032)
6.9 Asia Pacific Molecular Imaging Device Market Y-o-Y Growth Rate Comparison 2018–2032
6.9.1 Asia Pacific Molecular Imaging Device Market Y-o-Y Growth Rate by Region
6.9.2 Asia Pacific Molecular Imaging Device Market Y-o-Y Growth Rate by Technology
6.9.3 Asia Pacific Molecular Imaging Device Market Y-o-Y Growth Rate by Type of Imaging Agents
6.1 Asia Pacific Molecular Imaging Device Market Share Comparison 2017–2032
6.10.1 Asia Pacific Molecular Imaging Device Market Share by Region
6.10.2 Asia Pacific Molecular Imaging Device Market Share by Technology
6.10.3 Asia Pacific Molecular Imaging Device Market Share by Type of Imaging Agents
Chapter 7 South America Molecular Imaging Device Market Overview
7.1 South America Market Snapshot
7.1.1 Regional Overview
7.1.1.1 Brazil
7.1.1.2 Argentina
7.1.1.3 Rest of South America
7.2 South America Molecular Imaging Device Market Outlook (2017-2032)
7.2.1 South America Molecular Imaging Device Market Value (US$ Mn) and Volume (Units) (2017-2023)
7.2.2 South America Molecular Imaging Device Market Value (US$ Mn) and Volume (Units) (2024-2032)
7.3 South America Molecular Imaging Device Market by Region
7.3.1 South America Molecular Imaging Device Market Value (US$ Mn) and Volume (Units) Comparison by Region (2017-2032)
7.3.2 South America Molecular Imaging Device Market Attractiveness Analysis by Region, 2023–2032
7.4 South America Molecular Imaging Device Market by Technology
7.4.1 South America Molecular Imaging Device Market Value (US$ Mn) and Volume (Units) Comparison by Technology (2017-2032)
7.4.2 South America Molecular Imaging Device Market Attractiveness Analysis by Technology, 2023–2032
7.4.3 South America Molecular Imaging Device Market Attractiveness Analysis by Region, 2023–2032
7.5 South America Molecular Imaging Device Market by Type of Imaging Agents
7.5.1 South America Molecular Imaging Device Market Value (US$ Mn) and Volume (Units) Comparison by Type of Imaging Agents (2017-2032)
7.5.2 South America Molecular Imaging Device Market Attractiveness Analysis by Type of Imaging Agents, 2023–2032
7.6 South America Molecular Imaging Device Market Value (US$ Mn) and Volume (Units) by Region
7.6.1 South America Molecular Imaging Device Market Value (US$ Mn) and Volume (Units) Comparison by Region (2017-2023)
7.6.2 South America Molecular Imaging Device Market Value (US$ Mn) and Volume (Units) Comparison by Region (2024-2032)
7.7 South America Molecular Imaging Device Market Value (US$ Mn) and Volume (Units) by Technology
7.7.1 South America Molecular Imaging Device Market Value (US$ Mn) and Volume (Units) Comparison by Technology (2017-2023)
7.7.2 South America Molecular Imaging Device Market Value (US$ Mn) and Volume (Units) Comparison by Technology (2024-2032)
7.8 South America Molecular Imaging Device Market Value (US$ Mn) and Volume (Units) by Type of Imaging Agents
7.8.1 South America Molecular Imaging Device Market Value (US$ Mn) and Volume (Units) Comparison by Type of Imaging Agents (2017-2023)
7.8.2 South America Molecular Imaging Device Market Value (US$ Mn) and Volume (Units) Comparison by Type of Imaging Agents (2024-2032)
7.9 South America Molecular Imaging Device Market Y-o-Y Growth Rate Comparison 2018–2032
7.9.1 South America Molecular Imaging Device Market Y-o-Y Growth Rate by Region
7.9.2 South America Molecular Imaging Device Market Y-o-Y Growth Rate by Technology
7.9.3 South America Molecular Imaging Device Market Y-o-Y Growth Rate by Type of Imaging Agents
7.1 South America Molecular Imaging Device Market Share Comparison 2017–2032
7.10.1 South America Molecular Imaging Device Market Share by Region
7.10.2 South America Molecular Imaging Device Market Share by Technology
7.10.3 South America Molecular Imaging Device Market Share by Type of Imaging Agents
Chapter 8 Middle East and Africa Molecular Imaging Device Market Overview
8.1 Middle East and Africa Market Snapshot
8.1.1 Regional Overview
8.1.1.1 GCC
8.1.1.2 South Africa
8.1.1.3 Israel
8.1.1.4 Rest of Middle East and Africa
8.2 Middle East and Africa Molecular Imaging Device Market Outlook (2017-2032)
8.2.1 Middle East and Africa Molecular Imaging Device Market Value (US$ Mn) and Volume (Units) (2017-2023)
8.2.2 Middle East and Africa Molecular Imaging Device Market Value (US$ Mn) and Volume (Units) (2024-2032)
8.3 Middle East and Africa Molecular Imaging Device Market by Region
8.3.1 Middle East and Africa Molecular Imaging Device Market Value (US$ Mn) and Volume (Units) Comparison by Region (2017-2032)
8.3.2 Middle East and Africa Molecular Imaging Device Market Attractiveness Analysis by Region, 2023–2032
8.4 Middle East and Africa Molecular Imaging Device Market by Technology
8.4.1 Middle East and Africa Molecular Imaging Device Market Value (US$ Mn) and Volume (Units) Comparison by Technology (2017-2032)
8.4.2 Middle East and Africa Molecular Imaging Device Market Attractiveness Analysis by Technology, 2023–2032
8.4.3 Middle East and Africa Molecular Imaging Device Market Attractiveness Analysis by Region, 2023–2032
8.5 Middle East and Africa Molecular Imaging Device Market by Type of Imaging Agents
8.5.1 Middle East and Africa Molecular Imaging Device Market Value (US$ Mn) and Volume (Units) Comparison by Type of Imaging Agents (2017-2032)
8.5.2 Middle East and Africa Molecular Imaging Device Market Attractiveness Analysis by Type of Imaging Agents, 2023–2032
8.6 Middle East and Africa Molecular Imaging Device Market Value (US$ Mn) and Volume (Units) by Region
8.6.1 Middle East and Africa Molecular Imaging Device Market Value (US$ Mn) and Volume (Units) Comparison by Region (2017-2023)
8.6.2 Middle East and Africa Molecular Imaging Device Market Value (US$ Mn) and Volume (Units) Comparison by Region (2024-2032)
8.7 Middle East and Africa Molecular Imaging Device Market Value (US$ Mn) and Volume (Units) by Technology
8.7.1 Middle East and Africa Molecular Imaging Device Market Value (US$ Mn) and Volume (Units) Comparison by Technology (2017-2023)
8.7.2 Middle East and Africa Molecular Imaging Device Market Value (US$ Mn) and Volume (Units) Comparison by Technology (2024-2032)
8.8 Middle East and Africa Molecular Imaging Device Market Value (US$ Mn) and Volume (Units) by Type of Imaging Agents
8.8.1 Middle East and Africa Molecular Imaging Device Market Value (US$ Mn) and Volume (Units) Comparison by Type of Imaging Agents (2017-2023)
8.8.2 Middle East and Africa Molecular Imaging Device Market Value (US$ Mn) and Volume (Units) Comparison by Type of Imaging Agents (2024-2032)
8.9 Middle East and Africa Molecular Imaging Device Market Y-o-Y Growth Rate Comparison 2018–2032
8.9.1 Middle East and Africa Molecular Imaging Device Market Y-o-Y Growth Rate by Region
8.9.2 Middle East and Africa Molecular Imaging Device Market Y-o-Y Growth Rate by Technology
8.9.3 Middle East and Africa Molecular Imaging Device Market Y-o-Y Growth Rate by Type of Imaging Agents
8.1 Middle East and Africa Molecular Imaging Device Market Share Comparison 2017–2032
8.10.1 Middle East and Africa Molecular Imaging Device Market Share by Region
8.10.2 Middle East and Africa Molecular Imaging Device Market Share by Technology
8.10.3 Middle East and Africa Molecular Imaging Device Market Share by Type of Imaging Agents
Chapter 9 Methodology and Data Source
9.1 Research Approach/ Methodology
9.2 Market Size Estimation
9.3 Market Breakdown and Data Triangulation
9.4 Data Source
9.4.1 Secondary Sources
9.4.2 Primary Sources
